Suzano Reports Record Operating Cash Generation of R$22.6 billion in 2022
Suzano, the world’s largest hardwood pulp producer, announces its financial statements for the full fiscal year of 2022.
- FY22 Net revenues of R$49.8 billion, a 22% increase on FY21
- FY22 Adjusted EBTIDA of R$28.2 billion, a 20% increase on FY21
- FY22 Operating cash generation of R$22.6 billion, a 20% increase on FY21
- FY22 Pulp sales totalled 10.6 million tons, in line with FY21
- FY22 Paper sales totalled 1.3 million tons, a 1% increase on FY21 sales volume
- FY22 Operating costs (excluding downtime) were R$855 per ton, a 28% increase on FY21
2022’s strong results reflect buoyant global pulp prices and pulp sales volume, which offset significant pressures from production costs and global logistics challenges experienced across the value chain. This stability in sales volume, combined with a favourable exchange rate and higher prices, supported record net revenues of R$49.8 billion.
Cash generated across the period supported Suzano’s deleveraging, despite an acceleration in CAPEX and long-term investments. The net debt to adjusted EBITDA ratio (US Dollars) fell from 2.4x in 2021 to 2.0x in 2022. On the bottom line, Suzano registered a net income of R$23.4 billion.
Walter Schalka, CEO of Suzano, said:
“Supported by our structural competitiveness and a positive price trend, Suzano has once again demonstrated its capacity to generate cash in an environment of sharp cost increases and against the largest investment cycle to date.”
After investing R$32.6 billion between 2019 and 2022, Suzano plans to invest over R$18.5 billion in 2023.
Other initiatives during 2022 included the completion of a port terminal in Maranhão state, ongoing modernisation advances of the Aracruz and Jacareí units and expansion of its forest bases, the launch of Suzano Ventures and Biomas (in partnership with five other companies), and advances in the construction of a textile fibre plant in Finland (via the Woodspin JV) in partnership with Spinnova. Suzano also announced the acquisition of Kimberly-Clark´s tissue business in Brazil, which is still pending approval by Brazil’s antitrust agency CADE. Finally, Suzano continued its capital allocation programme with a dividend distribution of R$4.2 billion and the disbursement of R$1.9 billion in various share repurchase programmes.
On a sustainability front, progress achieved towards Suzano’s 15 long-term targets (the Commitments to Renewing Life) will be detailed in Suzano’s Annual Sustainability Report, which will be published soon.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230228006428/en/
Contact information
Hawthorn Advisors
suzano@hawthornadvisors.com
About Business Wire
Business Wire(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
AriBio Co., Ltd. to Present Biomarker Data for AR1001 from the Mild to Moderate Alzheimer’s Disease Phase 2 Study at the International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders (AD/PD™ 2023)31.3.2023 18:00:00 CEST | Press release
AriBio Co., Ltd. announced that David Greeley MD, Chief Medical Officer at AriBio, will present biomarker data from the completed phase 2 study in patients with mild to moderate Alzheimer’s disease who were treated with 10mg and 30mg of AR1001. AR1001 is a potent PDE5 inhibitor with preliminary efficacy in cognition, and preclinical effects on neuron apoptosis inhibition, promotion of neurogenesis, increase in neuroplasticity, and stimulation of autophagy to remove toxic proteins. The phase 2 study was a double-blind, randomized, placebo-controlled, multi-center trial to evaluate the safety and preliminary efficacy of AR1001 over 26 and 52 weeks of treatment in patients with mild to moderate Alzheimer’s disease. The trial enrolled 210 patients at 21 research centers in the United States. Plasma collected from patients at baseline, week 26 and week 52 was analyzed by Quantarix using the Simoa HD-X analyzer. Meaningful, statistically significant changes were found over 52 weeks of treatm
KANEKA: “Development of Polymer Synthesis Technology by Microorganisms using CO2 as Direct Raw Material” selected as a NEDO Green Innovation Fund Project”31.3.2023 16:09:00 CEST | Press release
Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Minoru Tanaka; hereinafter "Kaneka"), Bacchus Bio innovation Co., Ltd (Headquarters: Kobe-city, Hyogo; President: Mikio Tanji; hereinafter "Bacchus"), JGC Holdings Corporation (Headquarters: Yokohama-city Kanagawa; Chairman and CEO: Masayuki Sato; hereinafter "JGC HD"), and Shimadzu Corporation (Headquarters: Kyoto-city, Kyoto; President: Yasunori Yamamoto; hereinafter "Shimadzu") have announced that the proposal of a joint project, “Development of Polymer Synthesis Technology by microorganisms using CO2 as direct raw material (hereinafter referred to as ‘the Project’)” had been selected by the "Green Innovation Fund Project*1 / Promotion of Carbon Recycling Using CO2 from Biomanufacturing Technology as a Direct Raw Material” as a planned implementation sponsored by the New Energy and Industrial Technology Development Organization (NEDO). This press release features multimedia. View the full release here: https://www.busine
Allianz Appoints Leadership for Allianz Commercial Key Markets31.3.2023 15:11:00 CEST | Press release
As part of the implementation of its ‘Integrated Commercial’ strategy to better serve the full Commercial segment, Allianz Group today announced the leadership for four of its largest Property and Casualty Commercial insurance markets: Australia, France, Germany and the United Kingdom. In each country, the appointed single Commercial lead will represent the integrated Allianz Commercial business and bring to the market Allianz’s full set of solutions for specialty clients, large corporates, and mid-sized companies, simplifying and enhancing the experience of clients and distribution partners. “The appointment of the regional leaders in our core Allianz Commercial markets is an important, concrete step toward realizing our new integrated model, which brings together our Mid Corporate and Large Corporate insurance business for the benefit of our clients and distribution partners,” said Chris Townsend, Member of the Allianz SE Board of Management. Townsend added, “As one face to the marke
Huawei Releases 2022 Annual Report: Steady Operations, Sustainable Survival and Development31.3.2023 11:59:00 CEST | Press release
Huawei released its 2022 Annual Report today. The company reports steady operations throughout 2022, having generated CNY642.3 billion in revenue and CNY35.6 billion in net profits. Huawei continues to strengthen investment in R&D, with an annual expenditure of CNY161.5 billion in 2022, representing 25.1% of the company's annual revenue and bringing its total R&D expenditure over the past 10 years to more than CNY977.3 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230331005166/en/ (Photo: Huawei) "In 2022, a challenging external environment and non-market factors continued to take a toll on Huawei's operations", said Eric Xu, Huawei's Rotating Chairman, at the company's annual report press conference. "In the midst of this storm, we kept racing ahead, doing everything in our power to maintain business continuity and serve our customers. We also went to great lengths to grow the harvest – generating a steady stream
L&T Technology Services and Ansys set up CoE for Digital Twin31.3.2023 09:30:00 CEST | Press release
L&T Technology Services Limited (BSE: 540115, NSE: LTTS), a leading global pure-play engineering services company, and Ansys, a global leader and pioneer of Multiphysics engineering simulation software have signed an MOU to establish the LTTS-Ansys Center of Excellence (CoE) for Digital Twin. The center will support LTTS in demonstrating industry use cases, develop future facing solutions, and enable its customers to optimize design, manufacturing, and supply chain processes. Ansys' Twin Builder solution will allow LTTS to further expand its market share in digital twin areas. The digital twin market is valued at $6.5 billion and is expected to reach $125.7 billion by 2030, growing at a CAGR of 39.48%. The CoE will help LTTS showcase digital twin proofs of concept to its customers and speed up their adoption. The collaboration will enable LTTS to meet the growing demand for digital twin solutions and provide access to emerging talent in the technology market. The joint efforts of Ansys